Clinical trials
Phase 2 Lymphoma, Large B-Cell, Diffuse trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genmab | 2 |
| Seagen Inc. | 2 |
| Cellectar Biosciences, Inc. | 1 |
| Czech Lymphoma Study Group | 1 |
| Debiopharm International SA | 1 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 1 |
| Incyte Corporation | 1 |
| International Extranodal Lymphoma Study Group (IELSG) | 1 |
| MedImmune LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 15 |
| Lymphoma, Non-Hodgkin | 7 |
| Lymphoma | 5 |
| Recurrence | 4 |
| Hematologic Diseases | 3 |
| Lymphoma, B-Cell | 3 |
| Immunoproliferative Disorders | 2 |
| Lymphoproliferative Disorders | 2 |
| Neoplasms | 2 |
| Blood Protein Disorders | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.